Skip Navigation

Visiting Dana-Farber? See our prescreening and mask requirements.

Breast Oncology Program

About the Breast Oncology Program

  • New Patient Appointments
    877-442-3324

    Make Appointment Online
    Dana-Farber Brigham Cancer Center logo
    US News adult badge - smaller

  • Center for BRCA and Related Genes

    Mutations in BRCA1, BRCA2, and BRCA-related genes confer increased risk of certain cancers when inherited. These mutations can also be acquired by the cancers themselves. The Center for BRCA and Related Genes provides comprehensive care for patients with inherited and acquired mutations, including clinical therapeutic trials, trials of risk-reducing strategies, and studies of novel early detection markers.

  • More Information

    new patient coordinators

    Becoming a Patient

    As a new Dana-Farber patient, find answers to questions about your first visit: what to bring, how to find us, where to park, and how to prepare.

    cover supportive resources brochure

    Support Services and Amenities

    We offer a wide range of services, from financial planning to creative arts to spiritual counsel, to support our patients through their cancer experiences.

    patient rating stars

    How Our Patients Rate Dana-Farber

    See patient satisfaction survey results for different Dana-Farber locations collected by Press Ganey, an independent company experienced in patient satisfaction surveying.

  • More Information on Breast Cancer

    Claudia Kilvert and her husband.
    Insight Blog
    8/28/2023

    Tailored Treatment and Support for Older Adults with Breast Cancer 

    • Patient Stories, Adult
    • Breast Cancer
    Sara M. Tolaney, MD, MPH
    News Releases
    8/23/2023

    Final overall study analysis continues to show benefit of sacituzumab govitecan in advanced HR+ breast cancer

    • Research
    • Breast Cancer
    An illustration showing a person getting a mammogram with a doctor who is looking at the results.
    Insight Blog
    8/16/2023

    What to Know About the Types of Breast Cancer Screening 

    • Breast Cancer
    Judy E. Garber, MD, MPH
    Insight Blog
    6/26/2023

    What’s the Connection Between BRCA and Ashkenazi Jewish Ancestry? 

    • BRCA
    • Ovarian Cancer
    • Prostate Cancer
    • Genitourinary Cancer
    • Pancreatic Cancer
    • Gastrointestinal Cancer
    • Cancer Genetics
    • Breast Cancer
    Dipanjan Chowdhury, PhD
    News Releases
    6/8/2023

    New study suggests simple test could detect breast and ovarian cancer risk without genetic sequencing

    • Ovarian Cancer
    • Breast Cancer
    Cancer survivor Susanne Greelish (right) came to Dana-Farber for breast cancer treatment in 2018 at the suggestion of her friend and business partner Laurie Peck (left), who now works in Human Resources at Dana-Farber.
    Insight Blog
    6/6/2023

    For Breast and Kidney Cancer Survivor, Ongoing Care is Sweet  

    • Patient Stories, Adult
    • Breast Cancer
    _
    News Releases
    5/25/2023

    Women with breast cancer shed pounds thanks to telephone-based weight loss program, clinical trial finds

    • Research
    • Breast Cancer
    L to R: Christopher Lathan, MD, MS, MPH, Chief Clinical Access and Equity Officer##SEMICOLON## Magnolia Contreras, MSW, MBA — VP, Community Health##SEMICOLON## Joyce F. Liu, MD, MPH — Gynecologic Oncology##SEMICOLON## Erica L. Mayer, MD, MPH — Breast Oncology##SEMICOLON## Rachel A. Freedman, MD, MPH — Breast Oncology##SEMICOLON## Alexi A. Wright, MD, MPH — Gynecologic Oncology
    News Releases
    5/11/2023

    Boston women unite to discuss how Dana-Farber is addressing inequities in breast and gynecologic cancer care

    • Inclusion, Diversity & Equity
    • Gynecologic Cancer
    • Breast Cancer
    An illustration of the PI3Kβ protein (shown in purple) targeted by a drug molecule. Photo Credit: Hassan Tahini from ScienceBrush
    Insight Blog
    5/10/2023

    Research Drives Key Protein from the Shadows to Reveal Its Role in Breast Cancer Subtype 

    • Research
    • Breast Cancer